Enhanced Fos expression in rat lumbar spinal cord cultured with cerebrospinal fluid from patients with amyotrophic lateral sclerosis

Neurological Research

Volumn 21, Issue 3, 1999, Pages 309-312

  Manabe, Yasuhiro ^a   Kashihara, Kenichi ^a   Shiro, Yoshihiko ^a   Shohmori, Toshikiyo ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Amyotrophic lateral sclerosis; C fos expression; Cerebrospinal fluid; Slice culture; Spinal cord

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; LUMBAR SPINAL CORD; MALE; NEUROTOXICITY; NONHUMAN; ONCOGENE C FOS; ORGAN CULTURE; RAT; SPINAL CORD DORSAL HORN;

EID: 0032913118     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11740937     Document Type: Article

References (25)

1. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic aminoacids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988; 24: 446-449
2. Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL, Coyle JT. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 18-25
3. Hugon J, Tabaraud F, Rigaud M, Vallat JM, Dumas M. Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease. Neurology 1989; 39: 956-958
4. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 3-8
5. Lin CL, Bristol LA, Jin L, Dykes-Hobery M, Cramford T, Clawson L, Rothstein JD. Aberant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589-602
6. Nagai M, Abe K, Okamoto K, Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244: 165-168
7. De Belleroche J, Orrell RW, Virgo L. Amyotrophic lateral sclerosis: Recent advances in understanding disease mechanisms. J Neuropathol Exp Neurol 1996; 55: 747-757
8. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral scoerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 1995; 676: 196-204
9. Estevez AG, Stutzmann J-M, Barbeito L. Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motorneuron-enriched cultures. Eur J Pharmacol 1995; 280: 47-53
10. Rothstein JD, Kuncl R, Chaudhry V. Excitatory amino acids in amyotrophic lateral sclerosis: An up date. Ann Neurol 1991; 30: 224-225
11. Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ. CSF and plasma amino acid levels in motor neuron disease: Elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995; 4: 209-216
12. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464-1468
13. Rothstein JD, Van Kammen M, Levy AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73-84
14. Bristol LA, Rothstein JD. Glutamate transporter gene expression in amyotrophic lateral sclerosis. Ann Neurol 1996; 38: 73-84
15. Perry TL, Hensen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987; 37: 1845-1848
16. Perry TL, Krieger C, Hansen S, Eisen A. Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid. Ann Neurol 1990; 28: 12-17
17. Presley RW, Menetrey D, Levine JD, Basbaum AI. Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990; 10: 323-335
18. Hanba M, Muro M, Hiraide T, Ozawa H. Expression of c-fos-like protein in the rat brain after injection of interleukin-1-beta into the gingiva. Brain Res Bull 1994; 34: 61-68
19. Herdegen T, Fiallos-Estrada CE, Schmid W, Bravo R, Zimmermann M. The transcription factors c-JUN, JUN D and CREB, but not FOS and KROX-24, are differentially regulated in axotomized neurons following transection of rat sciatic nerve. Molec Brain Res 1992; 14: 155-165
20. Jenkins R, O'Shea R, Thomas KL, Hunt SP. c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat. Neuroscience 1993; 53: 447-455
21. Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 1993; 341: 265-268
22. Arancio O, Yoshimura M, Murase K, MacPermott AB. The distribution of excitatory amino acid receptors on acutely dissociated dorsal horn neurons from postnatal rats. Neurosci 1993; 52: 159-167
23. Henley JM, Jenkis R, Hunt SP. Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharm 1993; 32: 37-41
24. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Mia GG, Schilling K, Robertson LM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 166-169
25. Anderson AJ, Cummings BJ, Cotman CW. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: Association with pathology. Exp Neurol 1994; 125: 186-195